Veru (VERU) Return on Equity [ROE] (2013 - 2026)
Veru's Return on Equity [ROE] came in at -70.91% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 100.37 percentage points from -171.28% a year earlier but down 6.09 percentage points from the prior quarter.
Veru (VERU) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Veru's Return on Equity [ROE] was -61.92%, up 76.50 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -1.15 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Equity [ROE] was -138.42% in FY2024 (+43.39 pp), -181.80% in FY2023 (-110.98 pp), -70.83% in FY2022 (-78.84 pp) and 8.01% in FY2021 (+68.78 pp).
- The five-year range for quarterly Return on Equity [ROE] is -594.98% (fiscal Q3 2023) to 4.78% (fiscal Q4 2021).
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +66.13 percentage points over the last seven quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q3 2024 (a gain of 504.67 percentage points), and the weakest in fiscal Q3 2023 (a drop of 557.77 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Veru | 61.31 Mn | -48.96 Mn | - | -70.91% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.91% |
| Mar 31, 2026 | -64.83% |
| Dec 31, 2025 | -106.43% |
| Jun 30, 2025 | -171.28% |
| Mar 31, 2025 | -146.00% |
| Dec 31, 2024 | -125.29% |
| Sep 30, 2024 | -103.68% |
| Jun 30, 2024 | -90.31% |
| Mar 31, 2024 | -80.48% |
| Dec 31, 2023 | -175.98% |
| Sep 30, 2023 | -462.02% |
| Jun 30, 2023 | -594.98% |
| Mar 31, 2023 | -383.03% |
| Dec 31, 2022 | -176.33% |
| Sep 30, 2022 | -84.18% |
| Jun 30, 2022 | -37.21% |
| Mar 31, 2022 | -19.40% |
| Dec 31, 2021 | -10.72% |
| Sep 30, 2021 | 4.78% |
| Jun 30, 2021 | -0.09% |
Veru Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VERU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();